CSPG4: a prototype oncoantigen for translational immunotherapy studies

Thanks to striking progress in both the understanding of anti-tumor immune response and the characterization of several tumor associated antigens (TAA), a more rational design and more sophisticated strategies for anti-tumor vaccination have been possible. However, the effectiveness of cancer vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolih, Valeria, Barutello, Giuseppina, Iussich, Selina, De Maria, Raffaella, Quaglino, Elena, Buracco, Paolo, Cavallo, Federica, Riccardo, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494135/
https://www.ncbi.nlm.nih.gov/pubmed/28668095
http://dx.doi.org/10.1186/s12967-017-1250-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494135/
https://www.ncbi.nlm.nih.gov/pubmed/28668095
http://dx.doi.org/10.1186/s12967-017-1250-4

Ejemplares similares